Global Antiviral Drugs Market to 2032
Overview
The Global Antiviral Drugs Market is expected to reach a 121.53 USD Billion by 2032 and is projected to grow at a CAGR of 6.23% from 2025 to 2032.
Revenue, 2024 (USD Billion)
78.12
Forecast, 2032 (USD Billion)
121.53
CAGR, 2024 - 2032
6.23%
Report Coverage
Global
Global Antiviral Drugs Market 2018-2032 USD Billion
Global Antiviral Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 78.12 USD Billion
- Projected Market Size (2032): 121.53 USD Billion
- CAGR (2025-2032): 6.23%
Key Findings of Global Antiviral Drugs Market
- The Global Antiviral Drugs Market was valued at 121.53 USD Billion in 2024.
- The Global Antiviral Drugs Market is likely to grow at a CAGR of 6.23% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Topical in Products Segment accounted for the largest share of the market with a revenue of 78.12 USD Billion
- The fastest growing segment Influenza in Indication Segment grew Fastest with a CAGR of 8.06% during the forecast period from 2024 to 2032.
Global Antiviral Drugs Market Scope
Global Antiviral Drugs Market Segmentation & Scope
Products
- Oral
- Topical
- Parenteral
Patient
- Geriatric
- Child
- Adult
Indication
- Hepatitis B Virus
- Respiratory Syncytial Virus
- Coronavirus Infection
- Others
- Influenza
- Human Immunodeficiency Virus (HIV)
- Hepatitis C Virus
- Herpes Simplex Virus
- Human Cytomegalovirus (HCMV)
- Varicella-Zoster Virus (VZV)
Distribution Channel
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
End User
- Others
- Home Healthcare
- Hospitals
- Speciality Centers
- Ambultatory Centres
- Clinics
Drug
- Generic
- Branded
Global Antiviral Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 78.12 USD Billion |
| Market Value in 2032 | 121.53 USD Billion |
| CAGR (2025-2032) | 6.23% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Products,Patient,Indication,Distribution Channel,End User,Drug |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 78.12 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 34,236.66 USD Million in 2024.
Segments and Scope
-
Global Antiviral Drugs Market to 2032, By Products
- Topical is the largest segment in Global Antiviral Drugs Market to 2032 with a revenue of 78.12 USD Billion in the year 2024.
- Oral is the Fastest growing segment in Global Antiviral Drugs Market to 2032 with a Growth rate of 6.23 % in forecast period 2025-2032.
-
Global Antiviral Drugs Market to 2032, By Patient
- Geriatric is the largest segment in Global Antiviral Drugs Market to 2032 with a revenue of 38.37 USD Billion in the year 2024.
- Geriatric is the Fastest growing segment in Global Antiviral Drugs Market to 2032 with a Growth rate of 7.30 % in forecast period 2025-2032.
-
Global Antiviral Drugs Market to 2032, By Indication
- Influenza is the largest segment in Global Antiviral Drugs Market to 2032 with a revenue of 26.99 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in Global Antiviral Drugs Market to 2032 with a Growth rate of 8.06 % in forecast period 2025-2032.
-
Global Antiviral Drugs Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Global Antiviral Drugs Market to 2032 with a revenue of 42.24 USD Billion in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Global Antiviral Drugs Market to 2032 with a Growth rate of 7.13 % in forecast period 2025-2032.
-
Global Antiviral Drugs Market to 2032, By End User
- Hospitals is the largest segment in Global Antiviral Drugs Market to 2032 with a revenue of 40.62 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Global Antiviral Drugs Market to 2032 with a Growth rate of 7.29 % in forecast period 2025-2032.
-
Global Antiviral Drugs Market to 2032, By Drug
- Generic is the largest segment in Global Antiviral Drugs Market to 2032 with a revenue of 51.24 USD Billion in the year 2024.
- Generic is the Fastest growing segment in Global Antiviral Drugs Market to 2032 with a Growth rate of 6.49 % in forecast period 2025-2032.
Global Antiviral Drugs Market Company Share Analysis
| Company Name |
|
||
| Teva Pharmaceutical Industries Ltd. | |||
| Pfizer Inc. | |||
| Gilead Sciences, Inc. | |||
| GSK plc. | |||
| F. Hoffmann-La Roche Ltd. | |||
Global Antiviral Drugs Market Geographical Sales Distribution, 2018-2032 USD Billion
Global Antiviral Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Global Antiviral Drugs Market is segmented based on Segmentation Products,Patient,Indication,Distribution Channel,End User,Drug.
Global Antiviral Drugs Market was valued at USD 78.12(Revenue in USD Billion) in 2021.
Global Antiviral Drugs Market is projected to grow at a CAGR of 6.23% during the forecast period of 2024 to 2032.
The Topical segment is expected to dominate the Global Antiviral Drugs Market, holding a largest market share of 78.12 USD Billion in 2024
Global Antiviral Drugs Market Scope
Global Antiviral Drugs Market Segmentation & Scope
Products
- Oral
- Topical
- Parenteral
Patient
- Geriatric
- Child
- Adult
Indication
- Hepatitis B Virus
- Respiratory Syncytial Virus
- Coronavirus Infection
- Others
- Influenza
- Human Immunodeficiency Virus (HIV)
- Hepatitis C Virus
- Herpes Simplex Virus
- Human Cytomegalovirus (HCMV)
- Varicella-Zoster Virus (VZV)
Distribution Channel
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
End User
- Others
- Home Healthcare
- Hospitals
- Speciality Centers
- Ambultatory Centres
- Clinics
Drug
- Generic
- Branded
Frequently Asked Questions
The Global Antiviral Drugs Market is segmented based on Segmentation Products,Patient,Indication,Distribution Channel,End User,Drug.
Global Antiviral Drugs Market was valued at USD 78.12(Revenue in USD Billion) in 2021.
Global Antiviral Drugs Market is projected to grow at a CAGR of 6.23% during the forecast period of 2024 to 2032.
The estimated market value of the Global Antiviral Drugs Market for final year is USD 121.53 (USD Billion).
Global Antiviral Drugs Market Company Profiling
Frequently Asked Questions
The Global Antiviral Drugs Market is segmented based on Segmentation Products,Patient,Indication,Distribution Channel,End User,Drug.
Global Antiviral Drugs Market was valued at USD 78.12(Revenue in USD Billion) in 2021.
Global Antiviral Drugs Market is projected to grow at a CAGR of 6.23% during the forecast period of 2024 to 2032.
The estimated market value of the Global Antiviral Drugs Market for final year is USD 121.53 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.